CureVac CEO replaced in midst of biotech's coronavirus push

Board chairman Ingmar Hoerr will take over for Daniel Menichella, who just last week was meeting with President Trump to discuss CureVac's coronavirus vaccine development.

CureVac CEO replaced in midst of biotech's coronavirus push
Board chairman Ingmar Hoerr will take over for Daniel Menichella, who just last week was meeting with President Trump to discuss CureVac's coronavirus vaccine development.